Member Info for cottoner

Here's the presentation

https://www.yourgene-health.com/images/Yourgene_-_2019_AGM_presentation_FINAL.pdf

To balance the discussion - there were certainly some periods of time this afternoon that only a limited amount of shares could be purchased online via Halifax.

I did a number of dummy trades and on a few occasions the maximum available was well under £2k's worth , once a few sells went thro' this limitation was relieved.

I would suggest that NFX don't 'have a lot of eggs in one basket', quite the contrary in fact.

On hindsight :-)

On hindsight we'd all be multi-millionaires.

'"Plan to drive material increases in shareholder value in the next 3-5 years."

Don't believe it's at all damaging to say the above , it doesn't mean they're going to wait for 3 years before planning to create material value, they're starting now and plan to have created a material increase in shareholder value by 3-5 years , not from 3-5 years.

IMO. :-)



Damaging?
I think not.

For info

Current MCAP is actually c£6.7m

268.7 million shares x 0.025

Extract from todays Times MArket report.

Among the smaller stocks, Mereo Biopharma, a pharmaceuticals company that focuses on developing treatments for patients with rare diseases, rose by more than 7 per cent after Cantor Fitzgerald issued a “buy” rating on the stock and a target price of 720p, citing the value-adding potential of its respiratory therapies. The shares closed up 3p, or 7.1 per cent, at 45½p.

Link blocked!!j

Here's the inverview

****************************/articles/q-a-with-dr-dan-gooding-ceo-of-nuformix-7fb2486/

yes agreed and he doesn't say '500k payment expected in a few days'

JH - you need to relisten the latest interview.

DG didn't say '500k payment expected in a few days'

Need to correct that "Shareholders were promised NXP001 payments by end June"

That's simply not true.

In the RNS of 30th May it said "with remaining milestone payments expected during June 2019)"

Expected and promised are completely different things.

IMO it was unwise to use the word 'expected' in an RNS as in time this gets put to one side and becomes a 'promised' date.

Hopefully NFX will learn from this and be more careful in their wording of RNSes in the future.

Better to under promise and over deliver or in fact better not to promise at all.

Worth noting that the first NXP001 milestone payment was triggered and RNSed on 14th Sept 2018.
The receipt of this milestone payment was RNSed on Nov 27th 2018.
A time lapse between triggering and payment of c 2.5 months.

Because there was no 'expected' date of the receipt of that payment mentioned , there was no rumblings about the lateness of the payment!

I

obw - actually states the number of shares in total 469,466,512 , on the RNS.

For historical accuracy , at one point , Nov 2017 , Spreadex held over 86m shares and 18.69%.

Also the very most they could have held after 18th July , i.e 3% is just over 14m shares.

Somebody's been buying a lot more in the past few days.

Pretty negative article in today's Sunday Times

Peter Long’s struggle to save Countrywide
The travel trade veteran faces an uphill task to rescue our biggest estate agency chain

extract

Numis analyst Chris Millington believes Long’s changes will fail to halt the decline, which in turn will force Countrywide to renegotiate with lenders, launch another cash call or sell some of its brands — or face breaching banking covenants by the end of next year.

“It feels like intensive care,” Millington said. “Regardless of who is at the helm, it feels like the rot has set in.”

hTTps://www.thetimes.co.uk/edition/business/peter-longs-struggle-to-save-countrywide-bv2vjz9dt

Regulatory Affairs Consultant
Salary/Rate£60 - £80/hour
LocationM15, Manchester, Greater Manchester
Posted 26/07/2019 (10:33) Just Added
CompanyYourgene Health Description

Due to the recent growth of Yourgene Health we are looking for a Regulatory Affairs Consultant to join our Quality and Regulatory department on a 6 month contract. This role will provide effective management of the company’s regulatory affairs strategy, in order to support and fulfil the company’s global commercial strategy. The role requires management and liaison with internal team functions, regulatory authorities, and partner organisations. Minimum qualifications are a degree in Life Sciences, either in genetics or molecular biology and significant experience working within a regulatory affairs arena. The role will require the management of a team of regulatory professionals.

ESSENTIAL DUTIES AND RESPONSIBILITIES

continues...

https://www.cv-library.co.uk/job/210487474/Regulatory-Affairs-Consultant

Ovoca Bio plc (LSE: OVB; ISE: OVXA) announces that Yuri Radchenko, a Non-Executive Director of the Company, has notified the board of his intention to step down with immediate effect due to personal circumstances.

As per the website he currently holds 14.29% (11,656,202) shares.

Snack sales on a high in US states where cannabis legal

Snack manufacturers are enjoying a boost in sales in American states that have decriminalised marijuana.

The four-year compound annual growth rate of snack sales in these ten states is 7.2 per cent, compared with 6 per cent where cannabis remains illegal, a report by the market research company Nielsen found. The same rate of growth for confectionery is 2 per cent in decriminalised states and 1.3 per cent in illegal states.

Nielsen concluded that decriminalisation of the drug “presents big opportunities for the American food and beverage market, particularly for the snack and confectionery category”.

An academic study published this year appears to support the findings.

On average, sales of crisps rose by 5.3 per cent, cookies by 4.1 per cent and ice cream 3.1 per cent in Colorado, Oregon and Washington after the states decriminalised marijuana.

Scientific research suggests that tetrahydrocannabinol, the psychoactive ingredient in marijuana, releases a hormone that triggers hunger pangs and a neurotransmitter that increases appetite, which is nicknamed “the munchies”. Tetrahydrocannabinol also appears to enhance the smell and taste of food.

Coca-Cola and other large food and drink companies are experimenting with adding cannabidiol, a non-psychoactive constituent of cannabis thought to have calming and pain-relieving properties, to their products.

This market could be worth $16 billion by 2025, according to a recent estimate by Cowen, an investment bank.

Recreational use of cannabis remains a federal offence and the drug is grouped in the same category of illegal substances as heroin and cocaine. However, the law is not enforced, leaving states to set their own rules.

hTTps://www.thetimes.co.uk/edition/business/snack-sales-on-a-high-in-states-where-cannabis-legal-bh2p6pxmw

As the Group grows we are announcing fewer deals to the stockmarket as the threshold for meeting commerciality becomes proportionally higher, but I am delighted to report that we continue to win new customers in all major regions supporting the +45% revenue growth that we have reported in the last 12 months.